Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma
Clinical trial NCT02505269 · COMPLETED
Trial details
- NCT number
- NCT02505269
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-07
- Primary completion
- 2019-06-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.